QurCan Therapeutics Inc.

Profile

QurCan Therapeutics is advancing the next wave of genetic medicines for CNS diseases with TERP (Target-Engineered Responsive Polymer) technology, a non-viral delivery platform enabling safe, repeat intravenous CNS delivery of RNAs to the brain.

qurcan therapeutics inc.

Website

qurcan.com

Contact


Event details

Date: June 22 - 25, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

23 in total